TY  - GEN
AU  - Morozova,Olena
AU  - Vojvodic,Milijana
AU  - Grinshtein,Natalie
AU  - Hansford,Loen M
AU  - Blakely,Kim M
AU  - Maslova,Alexandra
AU  - Hirst,Martin
AU  - Cezard,Timothee
AU  - Morin,Ryan D
AU  - Moore,Richard
AU  - Smith,Kristen M
AU  - Miller,Freda
AU  - Taylor,Paul
AU  - Thiessen,Nina
AU  - Varhol,Richard
AU  - Zhao,Yongjun
AU  - Jones,Steven
AU  - Moffat,Jason
AU  - Kislinger,Thomas
AU  - Moran,Michael F
AU  - Kaplan,David R
AU  - Marra,Marco A
TI  - System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma
SN  - 1557-3265
PY  - 2011///0202
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Aurora Kinase B
KW  - Aurora Kinases
KW  - Chromatography, Liquid
KW  - methods
KW  - Drug Evaluation, Preclinical
KW  - Gene Expression Profiling
KW  - Gene Expression Regulation, Neoplastic
KW  - Gene Knockdown Techniques
KW  - Humans
KW  - Microarray Analysis
KW  - Molecular Targeted Therapy
KW  - Neoplastic Stem Cells
KW  - metabolism
KW  - Neuroblastoma
KW  - drug therapy
KW  - Protein Kinase Inhibitors
KW  - Protein Serine-Threonine Kinases
KW  - antagonists & inhibitors
KW  - RNA, Small Interfering
KW  - pharmacology
KW  - Systems Biology
KW  - Tandem Mass Spectrometry
KW  - Therapies, Investigational
KW  - Validation Studies as Topic
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-10-0627
ER  -